Agrylin (anagrelide hydrochloride)
Active ingredients · Anagrelide Hydrochloride Anhydrous
.5 mg/1 · Capsule
By Takeda Pharmaceuticals America, Inc.
- NDC
- 54092-063
- Route
- Oral
- Therapeutic class
- Decreased Platelet Production [PE], Phosphodiesterase 3 Inhibitors [MoA], Platelet-reducing Agent
- Marketing category
- NDA
Package sizes
- 100 CAPSULE in 1 BOTTLE (54092-063-01)NDC 54092-063-01Available to order
Additional information
Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.
Request this medication
Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.

